PURA VIDA INVESTMENTS, LLC - 14 Apr 2022 Form 4/A - Amendment Insider Report for Oncocyte Corp (OCX)

Role
10%+ Owner
Signature
/s/ Efrem Kamen, Managing Member of Pura Vida Investments, LLC
Issuer symbol
OCX
Transactions as of
14 Apr 2022
Net transactions value
+$7,887,850
Form type
4/A - Amendment
Filing time
29 Apr 2022, 16:33:45 UTC
Date Of Original Report
18 Apr 2022
Previous filing
17 Sep 2021
Next filing
28 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock Purchase $2,219,809 +1,665,898 +29% $1.33 7,350,447 14 Apr 2022 By Pura Vida Master Fund, Ltd. F1, F2, F3
transaction OCX Common Stock Purchase $37,779 +30,790 +0.42% $1.23 7,381,237 14 Apr 2022 By Pura Vida Master Fund, Ltd. F2, F3
transaction OCX Common Stock Purchase $116,386 +92,370 +1.3% $1.26 7,473,607 14 Apr 2022 By Pura Vida Master Fund, Ltd. F2, F3
transaction OCX Common Stock Purchase $2,553,628 +1,916,419 +29% $1.33 8,455,823 14 Apr 2022 By the Managed Accounts F1, F2, F3
transaction OCX Common Stock Purchase $23,571 +19,210 +0.23% $1.23 8,475,033 14 Apr 2022 By the Managed Accounts F2, F3
transaction OCX Common Stock Purchase $72,614 +57,630 +0.68% $1.26 8,532,663 14 Apr 2022 By the Managed Accounts F2, F3
transaction OCX Common Stock Purchase $1,023,296 +767,952 $1.33 767,952 14 Apr 2022 By Pura Vida X Fund LP F1, F2, F3
transaction OCX Common Stock Purchase $1,840,766 +1,381,438 $1.33 1,381,438 14 Apr 2022 By the Retirement Trust F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Warrant to purchase common stock Purchase +832,949 832,949 14 Apr 2022 Common Stock 832,949 $1.53 By Pura Vida Master Fund, Ltd. F1, F2, F3, F4
transaction OCX Warrant to purchase common stock Purchase +383,976 383,976 14 Apr 2022 Common Stock 383,976 $1.53 By Pura Vida X Fund LP F1, F2, F3, F4
transaction OCX Warrant to purchase common stock Purchase +690,719 690,719 14 Apr 2022 Common Stock 690,719 $1.53 By the Retirement Trust F1, F2, F3, F4
transaction OCX Warrant to purchase common stock Purchase +958,209 958,209 14 Apr 2022 Common Stock 958,209 $1.53 By the Managed Accounts F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of common stock was purchased together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325.
F2 Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida X Fund LP (the "Pura Vida X Fund"), Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust"), and certain separately managed accounts (the "Managed Accounts," collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
F3 By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
F4 The Warrants are subject to an ownership blocker provision that prevents the holder from exercising the Warrants if it would beneficially hold more than 19.99% of the common stock following such exercise.

Remarks:

This amendment to the Form 4 is being filed solely to correct the address reported for Efrem Kamen.